A cost analysis of sorafenib for desmoid tumors.
Johns MS, Merritt WT 3rd, Rhodes L, Ford CN, Thompson M, Lee WM, Sheldon Y, Petrelli NJ, Tiesi GJ.
Johns MS, et al. Among authors: ford cn.
J Oncol Pharm Pract. 2023 Apr;29(3):663-668. doi: 10.1177/10781552221077927. Epub 2022 Feb 3.
J Oncol Pharm Pract. 2023.
PMID: 35112974
Clinical Trial.